Advertisement

The Lead

FDA Accepts ACEON Supplemental New Drug Application for Filing (2710)

March 11, 2005 4:35 am | Product Releases | Comments

MARIETTA, Ga. and PALO ALTO, Calif., Feb. 15 -- Solvay Pharmaceuticals, Inc. and CV Therapeutics, Inc. announced today that the U.S.

FDA Accepts ACEON Supplemental New Drug Application for Filing

February 17, 2005 6:24 am | Product Releases | Comments

MARIETTA, Ga. and PALO ALTO, Calif., Feb. 15 -- Solvay Pharmaceuticals, Inc. and CV Therapeutics,...

View Sample

FREE Email Newsletter

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading